Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Titel:
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Auteur:
Yu, Shengyuan Kim, Byung-Kun Guo, Aihong Kim, Man-Ho Zhang, Mingjie Wang, Zhen Liu, Jianguang Moon, Heui-Soo Tan, Ge Yang, Qian McGrath, Donnie Hanna, Michael Stock, David A Gao, Yanfei Croop, Robert Lu, Zhihong